ABUZUS BOSH OG′RIG′I
Ключевые слова:
abuzus bosh og’rig’i, migren, zo’riqish bosh og’rig’i, Xalqaro Bosh Og’rig’i Kasalliklari TasnifiАннотация
Abuzus bosh og’rig’i (ABO) - migren yoki zo’riqish bosh og’rig’i singari birlamchi bosh og’riqlari xurujlarini bartaraf etish uchun analgetiklar yoki triptanlar kabi boshqa dorilarni haddan tashqari iste'mol qilish natijasida yuzaga keladigan ikkilamchi bosh og'rig'idir. Aholining taxminan 1% vaqti-vaqti bilan oyiga 10 ga yaqin turli xil analgetiklar qabu qiladi. Tarqalishi, ijtimoiy-iqtisodiy xarajatlar, yuqori takrorlanish darajasi tufayli ABO ham sog'liqni saqlash tizimi, ham amaliyotchi shifokorlar uchun muhim muammodir. Maqolada ABO kelib chiqish tarixi, epidemiologiyasi, patofiziologiyasi, komorbidliligi, xavf omillari, profilaktikasi, diagnostik mezonlari va davolashning eng samarali yondashuvlari masalalari muhokama qilinadi.
Библиографические ссылки
G.B.D.H (2018)Global, regional, and national burden of migraine and tensiontype headache, 1990–2016: A systematic analysis for the global burden of disease study2016. Lancet Neurol 17(11):954–976.https://doi.org/10.1016/S1474 4422(18)30322-3
Steiner TJ et al (2020) Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21(1):137.https://doi.org/10.1186/s10194-020 01208-0
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.Cephalalgia, 2018.38(1): p. 1–211 DOI:https://doi.org/10.1177/0333102417738202
May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12(8):455 464. https://doi.org/10.1038/nrneurol.2 016.93
Negro A, Rocchietti-March M, Fiorillo M, Martelletti P (2011) Chronic migraine: current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci 15(12):1401–1420
Wakerley BR (2019) Medication-overuse headache. Pract Neurol 19(5):399– 403.https://doi.org/10.1136/practneurol-2018-002048
Russell MB (2019) Epidemiology and management of medication-overuse headache in the general population. Neurol Sci 40(Suppl 1):23–26.https:// doi.org/10.1007/s10072-019-03812-879
Martelletti P (2018) The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine. J Headache Pain (1):2.https://doi.org/10.1186/s10194-017-0830-2
Vandenbussche N, Laterza D, Lisicki M, Lloyd J, Lupi C, Tischler H, Toom K, Vandervorst F, Quintana S, Paemeleire K, Katsarava Z (2018) Medicationoveruse headache: a widely recognized entity amidst ongoing debate. J Headache Pain 19(1):50.https://doi.org/10.1186/s10194-018-0875 x
Diener HC, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 12(10):575–583.https://doi.org/10.1038/nrneurol.2016.124
Calabresi P, Cupini LM (2005) Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 26(2):62-68.https://doi.org/10.1016/j tips.2004.12.008
Lennox W. The use of ergotamine tartrate in migraine. N Engl J Med. 1934:210:1061-1065.
Peters G, Horton B. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin. 1951;26(9):153-161.
Horton B, Peters G. Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache. 1963;2:214-227.
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(Suppl 7):1-96.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9-160.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders,3rd edition. Cephalalgia. 2018;38(1):1-211.
Westergaard ML, Hansen EH, Glümer C, Olesen J, Jensen RH. Definitions of medicationoveruse headache in populationbased studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34(6):409-425.
Ayzenberg I, Katsarava Z, Sborowski A, et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012;32(5):373-381.
Vandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018;19(1):50.
Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (CdAS). Headache. 2011:51(5):693-706.
Wiendels NJ, van der Geest MCM, Neven AK, Ferrari MD, Laan LAEM. . Chronic daily headache in children and adolescents. Headache. 2005;45(6):678-683.
Prencipe M, Casini AR, Ferretti C, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry.2001;70(3):377-381
de Rijk P, Resseguier N, Donnet A. Headache characteristics and clinical features of elderly migraine patients. Headache. 2018;58(4):525-533.
Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12(10):575-583.
Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Neurology. 2006;67(1):109-113
Srikiatkhachorn A, le Grand SM, Supornsilpchai W, et al. Pathophysiology of medication overuse Headache-An update. Headache: The Journal of Head and Face Pain 2014;54:204–10.
Martelletti P. The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine. J Headache Pain2018;19.
Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in patients with cluster headache. Neurology 2006;67:109–1380
Cargnin S, Viana M, Sances G, et al. A systematic review and critical appraisal of gene polymorphism association studies in medication overuse headache. Cephalalgia2018;38:1361–
Schwedt TJ, Chong CD. Medication overuse headache: pathophysiological insights from structural and functional brain MRI research. Headache: The Journal of Head and Face Pain 2017;57:1173–8.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia,2013, 33: 629.
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache, 2008, 48: 1157-1168.
Limmroth V, Katsarava Z, Fritsche G et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology,2002, 59: 1011-1014.
Katsarava Z, Fritsche G, Muessig M et al. Clinical features of withdrawal headache fol lowing overuse of triptans and other headache drugs. Neurology,2001, 57: 1694–1698.
Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15- year period. Headache. 2006;46(5):766-772.
Vandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018;19(1):50.
Hagen K, Linde M, Steiner TJ, et al. Risk factors for medication-overuse headache: an 11- year follow up study. The Nord-Trondelag health studies. Pain. 2012;153(1):56-61.
Baumgartner C, Wessely P, Bingöl C et al (1989) Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 29:510– 514.https://doi.org/10.1111/j.1526 4610.1989.hed2908510.x
Mathew NT, Stubits E, Nigam MP (1982) Transformation of episodic migraine into daily headache: analysis of factors. Headache J Head Face Pain 22:66–68.https://doi.org/10.1111/j.1526-4610.1982.hed2202066.x
Hagen K, Linde M, Steiner TJ et al (2012) Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag health studies. Pain 153:56– 61. https://doi.org/10.1016/j.pain.2011.08.018
Ashina S, Serrano D, Lipton RB et al (2012) Depression and risk of transformation of episodic to chronic migraine. J Headache Pain 13:615– 624. https://doi.org/10.1007/s10194- 012-0479-9
Sarchielli P, Corbelli I, Messina P et al (2016) Psychopathological comorbidities in medication overuse headache: a multicentre clinical study. Eur J Neurol 23:85–91. https://doi.org/10.1111/ene.12794
Kristoffersen ES, Straand J, Russell MB, Lundqvist C (2016) Disability, anxiety and depression in patients with medication-overuse headache in primary care - the BIMOH study. Eur J Neurol 23:28–35.https://doi.org/10.1111/ene.12850
Bendtsen L, Munksgaard SB, Tassorelli C et al (2014) Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia 34:426 433. https://doi.org/10.1177/0333102413515338
Lampl C, Thomas H, Tassorelli C et al (2016) Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain 17(1):59.
https://doi.org/10.1186/s10194-016-0649-2
Curone M, Tullo V, Mea E et al (2011) Psychopathological profile of patients with chronic migraine and medication overuse : study and findings in 50 cases. Neurol Sci 32:177– 179.https://doi.org/10.1007/s10072-011-0527-281
Cupini LM, Murtas MD, Costa C et al (2009) Obsessive-compulsive disorder and migraine with medication-overuse headache: research submission. Headache 49:1005–1013. https://doi.org/10.1111/j.1526-4610.2009.01457.x
Radat F, Lanteri-Minet M (2010) What is the role of dependence-related behavior in medication-overuse headache? Headache 50:1597–1611. https:// doi.org/10.1111/j.1526-4610.2010.01755.x
Galli F, Pozzi G, Frustaci A et al (2011) Differences in the personality profile of medicationoveruse headache sufferers and drug addict patients: a comparative study using MMPI-2. Headache 51:1212–1227.https://doi.org/ 10.1111/j.1526-4610.2011.01978.x
Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81–89. https://doi.org/10.1016/S0304-3959(03)00293-8
Bigal ME, Liberman JN, Lipton RB (2006) Obesity and migraine: a population study.Neurology66:545 550. https://doi.org/10.1212/01.wnl.0000197218.05284.82
He Z, Dong L, Zhang Y et al (2015) Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China. Eur J Neurol 22:1228–1234.https://doi.org/10.1111/ene.12732
Westergaard ML, Glümer C, Hansen EH, Jensen RH (2016) Medication overuse, healthy lifestyle behaviour and stress in chronic headache: results from a population-based representative survey. Cephalalgia 36:15–28. https://doi.org/10.1177/0333102415578430
Hershey AD, Powers SW, Nelson TD et al (2009) Obesity in the pediatric headache population: a multicenter study. Headache J Head Face Pain 49: 170– 177. https://doi.org/10.1111/j.1526 4610.2008.01232.x
Pakalnis A, Kring D (2012) Chronic daily headache, medication overuse, and obesity in children and adolescents. J Child Neurol 27:577–580.https://doi. org/10.1177/0883073811420869
Sancisi E, Cevoli S, Vignatelli L et al (2010) Increased prevalence of sleep disorders in chronic headache: a case-control study. Headache 50:1464– 1472. https://doi.org/10.1111/j.1526-4610.2010.01711.x
Couch JR. Can medication overuse headache be treated by abrupt withdrawal of the
overused agent? Nat Clin Pract Neurol2006;2:654–5.
MacGregor EA, Steiner TJ, Davies PTG. Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension Type,Cluster and Medication-Overuse Headache. 3rd edition, 2010.
Katsarava Z, Limmroth V, Finke M, et al. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology2003;60:1682–1683.
Grande RB, Aaseth K, Benth J. Š., et al. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurology 2011;18:129–37.
Carlsen LN, Munksgaard SB, Jensen RH, et al. Complete detoxification is the most effective treatment of medicationoveruse headache: a randomized controlled open-label trial. Cephalalgia2018;38:225–36.
Williams DR, Stark RJ, lignocaine I. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003;23:963–71.
Andrasik F, Grazzi L, D'Amico D, et al. Mindfulness and headache: A "new" old treatment, with new findings. Cephalalgia2016;36:1192–205.
de Goffau MJ, Klaver ARE, Willemsen MG, et al. The effectiveness of treatments for patients with medication overuse headache: a systematic review and meta-analysis. J Pain 2017;18:615
